Jury Orders AndroGel Maker AbbVie to Pay $3M After Judge Rejected $150M

A U.S. jury on Monday ordered AbbVie Inc. to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury …

from News – Insurance Journal